UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia

European journal of clinical microbiology & infectious diseases, 2005-02, Vol.24 (2), p.111-118

2005

Volltextzugriff (PDF)

Daptomycin: first in a new class of antibiotics for complicated skin and soft-tissue infections

International journal of clinical practice (Esher), 2006-03, Vol.60 (3), p.370-378

Kern, W. V.

2006

Volltextzugriff (PDF)

Vancomycin versus Placebo for Treating Persistent Fever in Patients with Neutropenic Cancer Receiving Piperacillin-Tazobactam Monotherapy

Clinical infectious diseases, 2003-08, Vol.37 (3), p.382-389

2003

Volltextzugriff (PDF)

Postoperative nosocomial endophthalmitis: is perioperative antibiotic prophylaxis advisable? A single centre’s experience

The Journal of hospital infection, 2011-06, Vol.78 (2), p.138-142

2011

Volltextzugriff (PDF)

Prospective multicentre feasibility study of a quality of care indicator for intravenous to oral switch therapy with highly bioavailable antibiotics

Journal of antimicrobial chemotherapy, 2012-08, Vol.67 (8), p.2043-2046

2012

Volltextzugriff (PDF)

Non-Target Gene Mutations in the Development of Fluoroquinolone Resistance in Escherichia coli

Antimicrobial Agents and Chemotherapy, 2000-04, Vol.44 (4), p.814-820

2000

Volltextzugriff (PDF)

An AcrAB-mediated multidrug-resistant phenotype is maintained following restoration of wild-type activities by efflux pump genes and their regulators

International journal of antimicrobial agents, 2009-12, Vol.34 (6), p.602-604

2009

Volltextzugriff (PDF)

Moxifloxacin prophylaxis in neutropenic patients

Journal of antimicrobial chemotherapy, 2006-10, Vol.58 (4), p.891-894

2006

Volltextzugriff (PDF)

Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis

Journal of antimicrobial chemotherapy, 2008-05, Vol.61 (5), p.1076-1082

2008

Volltextzugriff (PDF)

Piperacillin–tazobactam monotherapy in high-risk febrile and neutropenic cancer patients

Clinical microbiology and infection, 2006-03, Vol.12 (3), p.212-216

2006

Volltextzugriff (PDF)

Impact of Fluoroquinolone Prophylaxis on Reduced Infection-Related Mortality among Patients with Neutropenia and Hematologic Malignancies

Clinical infectious diseases, 2005-04, Vol.40 (8), p.1087-1093

2005

Volltextzugriff (PDF)

Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump

Antimicrobial agents and chemotherapy, 2000, Vol.44 (1), p.10-13

2000

Volltextzugriff (PDF)

Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center

Antimicrobial Agents and Chemotherapy, 1994-04, Vol.38 (4), p.681-687

1994

Volltextzugriff (PDF)

Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli

Antimicrobial agents and chemotherapy, 1998-08, Vol.42 (8), p.2089-2094

1998

Volltextzugriff (PDF)

Imported leishmaniasis in Germany 2001-2004 : data of the SIMPID surveillance network

European journal of clinical microbiology & infectious diseases, 2005-07, Vol.24 (7), p.471-476

2005

Volltextzugriff (PDF)

Antibiotic use in two cohorts of German intensive care units

The Journal of hospital infection, 2006-11, Vol.64 (3), p.231-237

2006

Volltextzugriff (PDF)

Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer Chemotherapy

The New England journal of medicine, 1999-07, Vol.341 (5), p.312-318

1999

Volltextzugriff (PDF)

gyrA Mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli

Journal of antimicrobial chemotherapy, 1996-09, Vol.38 (3), p.443-456

1996

Volltextzugriff (PDF)

In vitro antimicrobial activity of moxifloxacin against bacterial strains isolated from blood of neutropenic cancer patients

European journal of clinical microbiology & infectious diseases, 2006-08, Vol.25 (8), p.537-540

2006

Volltextzugriff (PDF)

Anidulafungin versus Fluconazole for Invasive Candidiasis

The New England journal of medicine, 2007-06, Vol.356 (24), p.2472-2482

2007

Volltextzugriff (PDF)

Glycopeptide use at four university hospitals in southern Germany

Infection, 2002-10, Vol.30 (5), p.262-266

2002

Volltextzugriff (PDF)

Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers

Antimicrobial Agents and Chemotherapy, 1996-02, Vol.40 (2), p.387-392

1996

Volltextzugriff (PDF)

A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis

Antimicrobial Agents and Chemotherapy, 1994-03, Vol.38 (3), p.465-472

1994

Volltextzugriff (PDF)

Association of organic solvent tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coli

Journal of antimicrobial chemotherapy, 1998, Vol.41 (1), p.111-114

1998

Volltextzugriff (PDF)

Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer

Antimicrobial agents and chemotherapy, 1996-05, Vol.40 (5), p.1108-1115

1996

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Aktive Filter

ThemaAntibiotics. Antiinfectious Agents. Antiparasitic Agents

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(87)

Sprache

Englisch
(87)

Erscheinungsjahr

n.n

Thema

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia

Daptomycin: first in a new class of antibiotics for complicated skin and soft-tissue infections

Vancomycin versus Placebo for Treating Persistent Fever in Patients with Neutropenic Cancer Receiving Piperacillin-Tazobactam Monotherapy

Postoperative nosocomial endophthalmitis: is perioperative antibiotic prophylaxis advisable? A single centre’s experience

Prospective multicentre feasibility study of a quality of care indicator for intravenous to oral switch therapy with highly bioavailable antibiotics

Non-Target Gene Mutations in the Development of Fluoroquinolone Resistance in Escherichia coli

An AcrAB-mediated multidrug-resistant phenotype is maintained following restoration of wild-type activities by efflux pump genes and their regulators

Moxifloxacin prophylaxis in neutropenic patients

Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis

Piperacillin–tazobactam monotherapy in high-risk febrile and neutropenic cancer patients

Impact of Fluoroquinolone Prophylaxis on Reduced Infection-Related Mortality among Patients with Neutropenia and Hematologic Malignancies

Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump

Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center

Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli

Imported leishmaniasis in Germany 2001-2004 : data of the SIMPID surveillance network

Antibiotic use in two cohorts of German intensive care units

Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer Chemotherapy

gyrA Mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli

In vitro antimicrobial activity of moxifloxacin against bacterial strains isolated from blood of neutropenic cancer patients

Anidulafungin versus Fluconazole for Invasive Candidiasis

Glycopeptide use at four university hospitals in southern Germany

Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers

A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis

Association of organic solvent tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coli

Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer

Aktive Filter

Suchergebnisse filtern